A carregar...
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
BACKGROUND: The nucleic acid targeted pathogen reduction (PR) system utilizing amustaline (S‐303) and glutathione (GSH) is designed to inactivate blood‐borne pathogens and leukocytes in red blood cell concentrates (PR‐RBCC). Inactivation is attained after amustaline intercalates and forms covalent n...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027779/ https://ncbi.nlm.nih.gov/pubmed/31930533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15662 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|